Alivus Life Sciences (NSE:ALIVUS) Net Interest Margin (Bank Only) %


NSE:ALIVUS Alivus Life Sciences Ltd NSE:ALIVUS
86 GF Score
Price ₹1,130.10
GF Value ₹1,007.17
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Alivus Life Sciences Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

NSE:ALIVUS
86GF Score
Alivus Life Sciences Ltd NSE:ALIVUS
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Alivus Life Sciences (NSE:ALIVUS) Overvalued in 2026?

Based on GuruFocus' analysis, Alivus Life Sciences stock appears to be overvalued. The current stock price of ₹1,130.10 is trading 12.2% above its estimated GF Value™ of ₹1,007.17. GuruFocus considers Alivus Life Sciences to be Modestly Overvalued.

Key valuation signals for NSE:ALIVUS:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: ₹1,007.17 vs. price of ₹1,130.10 (12.2% above fair value)
  • GF Score™: 86/100 with 5 warning signs

No single metric tells the full story. See the NSE:ALIVUS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Alivus Life Sciences Business Description

Other Exchanges 543322:India
Address 470, Cardinal Gracious Road, 4th Floor, OIA House, Andheri (East), Mumbai, MH, IND, 400 099
Alivus Life Sciences Ltd develops, manufactures, and supplies high-quality active pharmaceutical ingredients for cardiovascular disease, central nervous system disorders, pain management, diabetes, urology, gastrointestinal disorders, and other therapeutic areas.
86GF Score

Get the complete analysis for NSE:ALIVUS

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,130.10
Price
₹1,007.17
GF Value